Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001374339-25-000001
Filing Date
2025-02-12
Accepted
2025-02-12 17:21:35
Documents
1
Period of Report
2025-02-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3816
  Complete submission text file 0001374339-25-000001.txt   5378
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Issuer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PROMIS NEUROSCIENCES INC. SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address
Cashman Neil (Reporting) CIK: 0001927064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41429 | Film No.: 25616131